DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Varespladib methyl is an investigational drug.
There have been 5 clinical trials for Varespladib methyl. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Syndrome, Acute Coronary Syndrome, and Snake Bites. The leading clinical trial sponsors are Anthera Pharmaceuticals, Ophirex, Inc., and Premier Research International LLC.
Recent Clinical Trials for Varespladib methyl
|Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite||Premier Research International LLC||Phase 2|
|Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite||Ophirex, Inc.||Phase 2|
|A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function||Anthera Pharmaceuticals||Phase 1|